Alkem stock gains 1.92 percent before October 7 investor meeting

Published on 10/07/2026 at 01:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Alkem stock rose before its October 7, 2026 meeting with HDFC Mutual Fund. Q1 FY27 revenue grew 10.95 percent, while net profit fell 21.21 percent.

Alkem, INE540L01014, Illustration mit AI erstellt.

Alkem Laboratories stock (ISIN INE540L01014) was last at INR 5,292 on the NSE on October 6, 2026, up 1.92 percent from the previous close. The company is scheduled to hold a one-on-one meeting with HDFC Mutual Fund in Mumbai on October 7, 2026, according to ScanX.

Investor meeting follows mixed quarter

The HDFC Mutual Fund meeting comes after Alkem reported Q1 FY27 results for the quarter ended June 30, 2026. Sahi reported consolidated revenue from operations of INR 37.4015 billion, a 10.95 percent year-over-year increase from INR 33.7114 billion.

The bottom line moved in the opposite direction. Consolidated net profit fell 21.21 percent year over year to INR 5.2 billion from INR 6.6 billion, with higher tax expenses cited as the main drag in the same Q1 FY27 report.

Neurology launch adds a growth angle

Alkem launched NeuCeno, a once-daily cenobamate treatment for adult partial-onset seizures, in India on September 16, 2026. The product is available in six tablet strengths, while clinical studies cited by Sahi showed up to a 78 percent reduction in seizure frequency with adjunctive use.

The launch gives the company a concrete chronic-therapy expansion point as revenue growth remains positive but earnings face tax pressure. For investors, the meeting with HDFC Mutual Fund offers a dated checkpoint for questions around domestic launches, margin resilience and the next quarter.

Hold rating meets lower-end valuation

MarketsMOJO upgraded Alkem from Sell to Hold on October 1, 2026, citing improved technical indicators and valuation metrics. The same assessment put Q1 FY27 profit after tax at INR 5.1995 billion, down 20.4 percent, and reported return on equity of 16.88 percent.

Alkem stock traded between INR 5,051 and INR 5,933.50 over the 52-week period ending October 6, 2026. Its market capitalization was INR 632.7 billion and volume was 63,620 shares on the same NSE quote.

Alkem stock ends at INR 5,292

Alkem stock was last at INR 5,292 on the NSE on October 6, 2026, with the daily gain standing at 1.92 percent. The October 7 meeting and the next quarterly update will keep revenue conversion and profit recovery at the center of the stock discussion.